Gemcitabine, capecitabine, docetaxel followed by radiotherapy for Pancreatic Cancer
Study Summary
This trial will study the safety and efficacy of a combination of Gemcitabine, Capecitabine, and Docetaxel in patients with locally advanced pancreatic cancer.
- Stage II Pancreatic Cancer
- Stage III Pancreatic Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 2 years
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Group I
1 of 2
Group II
1 of 2
Experimental Treatment
64 Total Participants · 2 Treatment Groups
Primary Treatment: Gemcitabine, capecitabine, docetaxel followed by radiotherapy · No Placebo Group · Phase 2 & 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:- Sherman, William H., Kyung Chu, John Chabot, John Allendorf, Beth Ann Schrope, Elizabeth Hecht, Brian Jin, et al.. 2014. “Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine Followed by Gemcitabine and Capecitabine/radiation Therapy and Surgery in Locally Advanced, Unresectable Pancreatic Adenocarcinoma”. Cancer. Wiley. doi:10.1002/cncr.29112.
- William Sherman 2009. "Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01065870.
Frequently Asked Questions
Are there any other ongoing trials that are testing the combination of Gemcitabine, capecitabine, and docetaxel before radiotherapy?
"As of right now, there are 1057 active studies for Gemcitabine, capecitabine, docetaxel followed by radiotherapy. Of these, 358 are in Phase 3. With several trials for Gemcitabine, capecitabine, docetaxel followed by radiotherapy running out of in Guangzhou, Guangdong, there are still a total of 53306 locations operating trials for Gemcitabine, capecitabine, docetaxel followed by radiotherapy." - Anonymous Online Contributor
Are there any spots still open in this research project?
"This study is not actively recruiting patients at this moment. The listing was originally created on December 1st, 2009 and was most recently edited on January 27th, 2014. If you are looking for other studies, 594 trials for cancer of the pancreas and 1057 for Gemcitabine, capecitabine, docetaxel followed by radiotherapy are still admitting patients." - Anonymous Online Contributor
What condition is the Gemcitabine, capecitabine, docetaxel followed by radiotherapy treatment most often used to improve?
"Gemcitabine, capecitabine, and docetaxel followed by radiotherapy is a common treatment for patients that have received adjuvant anthracycline-containing therapy. This treatment method is also effective for patients suffering from conditions such as head and soft tissue sarcoma, as well as colorectal carcinoma." - Anonymous Online Contributor